Evaluating Safety, Pharmacokinetics and Clinical Benefit of Silmitasertib (CX-4945) in Subjects With Moderate COVID-19
Clinical trial NCT04663737 · COMPLETED
Trial details
- NCT number
- NCT04663737
- Sponsor
- Senhwa Biosciences, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-30
- Primary completion
- 2021-08-16
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.